Literature DB >> 33622893

Risk Factors for Lymph Node Metastasis in Pathological T1b Colorectal Cancer.

Atsushi Naito1, Kazuya Iwamoto2, Masahisa Ohtsuka2, Mitsunobu Imasato2, Yujiro Nakahara2, Manabu Mikamori2, Kenta Furukawa2, Jeongho Moon2, Tadafumi Asaoka2, Kentaro Kishi2, Hiroki Akamatsu2.   

Abstract

BACKGROUND/AIM: The rate of lymph node metastasis (LNM) of colorectal carcinoma (CRC) with a submucosal (SM) invasion depth of 1000 µm or more can reach 12.5%, which is the most common reason for additional resection in daily practice. Other studies have reported that the rate of LNM is less than 2%, regardless of the depth of invasion, if the lesions show good histology, lymphovascular infiltration is negative, and tumor budding is limited. The purpose of this study was to investigate new risk factors for LNM in T1b colorectal cancer. PATIENTS AND METHODS: The 239 patients who were diagnosed with pathological T1b CRC after colorectal surgical resection at the Osaka Police Hospital in Japan between January 2008 and December 2018 were retrospectively reviewed in this study.
RESULTS: The LNM rate was 11.3% (27/239). The variables identified as being significant factors using multivariate analysis were: i) lymphatic invasion (Ly)-positive [odds ratio (OR)=5.97; 95% confidence interval (CI)=2.27-15.74], ii) female gender (OR=3.49; 95%CI=1.38-8.85), and iii) left-sided colorectal involvement (OR=4.98; 95%CI=1.22-20.39). If none of these risk factors were present with T1b, the LNM rate was 0% (0/28).
CONCLUSIONS: Ly-positive, female gender, and left-sided colorectal involvement could be risk factors for LNM in T1b CRC. Copyright
© 2021, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Lymph node metastasis; T1b colorectal cancer; risk factor

Year:  2021        PMID: 33622893      PMCID: PMC8045107          DOI: 10.21873/invivo.12341

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  17 in total

1.  Management of T1 colorectal carcinoma with special reference to criteria for curative endoscopic resection.

Authors:  Koichi Nakadoi; Shinji Tanaka; Hiroyuki Kanao; Motomi Terasaki; Sayaka Takata; Shiro Oka; Shigeto Yoshida; Koji Arihiro; Kazuaki Chayama
Journal:  J Gastroenterol Hepatol       Date:  2012-06       Impact factor: 4.029

2.  Correlations between lymph node metastasis and depth of submucosal invasion in submucosal invasive colorectal carcinoma: a Japanese collaborative study.

Authors:  Kazuaki Kitajima; Takahiro Fujimori; Shigehiko Fujii; Jun Takeda; Yasuo Ohkura; Hitoshi Kawamata; Toshihide Kumamoto; Shingo Ishiguro; Yo Kato; Tadakazu Shimoda; Akinori Iwashita; Yoichi Ajioka; Hidenobu Watanabe; Toshiaki Watanabe; Tetsuichiro Muto; Ko Nagasako
Journal:  J Gastroenterol       Date:  2004-06       Impact factor: 7.527

3.  Resection with en bloc removal of regional lymph node after endoscopic resection for T1 colorectal cancer.

Authors:  Hirotoshi Kobayashi; Tetsuro Higuchi; Hiroyuki Uetake; Satoru Iida; Toshiaki Ishikawa; Megumi Ishiguro; Kenichi Sugihara
Journal:  Ann Surg Oncol       Date:  2012-07-07       Impact factor: 5.344

4.  Pathological risk factors and predictive endoscopic factors for lymph node metastasis of T1 colorectal cancer: a single-center study of 846 lesions.

Authors:  Chihiro Yasue; Akiko Chino; Manabu Takamatsu; Ken Namikawa; Daisuke Ide; Shoichi Saito; Masahiro Igarashi; Junko Fujisaki
Journal:  J Gastroenterol       Date:  2019-02-27       Impact factor: 7.527

5.  Endoscopic resection of T1 colorectal cancer prior to surgery does not affect surgical adverse events and recurrence.

Authors:  Yusuke Yamaoka; Kenichiro Imai; Akio Shiomi; Hiroyasu Kagawa; Hitoshi Hino; Yushi Yamakawa; Tomohiro Yamaguchi; Yusuke Kinugasa; Yoshihiro Kishida; Sayo Ito; Kinichi Hotta; Toru Imai
Journal:  Surg Endosc       Date:  2019-12-09       Impact factor: 4.584

6.  Changing trends in the incidence, stage, survival, and screen-detection of colorectal cancer: a population-based study.

Authors:  Amit K Gupta; L Joseph Melton; Gloria M Petersen; Lawrence J Timmons; Santhi Swaroop Vege; William S Harmsen; Nancy N Diehl; Alan R Zinsmeister; David A Ahlquist
Journal:  Clin Gastroenterol Hepatol       Date:  2005-02       Impact factor: 11.382

7.  Condition of muscularis mucosae is a risk factor for lymph node metastasis in T1 colorectal carcinoma.

Authors:  Koichi Nakadoi; Shiro Oka; Shinji Tanaka; Nana Hayashi; Motomi Terasaki; Koji Arihiro; Fumio Shimamoto; Kazuaki Chayama
Journal:  Surg Endosc       Date:  2013-11-27       Impact factor: 4.584

8.  Surgical or endoscopic management of malignant colon polyps.

Authors:  Nikas Samuolis; Narimantas E Samalavicius; Audrius Dulskas; Rytis Markelis; Raimundas Lunevicius; Ugnius Mickys; Ugne Ringeleviciute
Journal:  ANZ J Surg       Date:  2018-10-22       Impact factor: 1.872

9.  A novel ability of endocytoscopy to diagnose histological grade of differentiation in T1 colorectal carcinomas.

Authors:  Tomoya Sako; Shin-Ei Kudo; Hideyuki Miyachi; Kunihiko Wakamura; Kenta Igarashi; Masashi Misawa; Yuichi Mori; Toyoki Kudo; Takemasa Hayashi; Atsushi Katagiri; Fumio Ishida; Takeshi Azuma; Haruhiro Inoue; Shigeharu Hamatani
Journal:  Endoscopy       Date:  2017-09-29       Impact factor: 10.093

10.  Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer.

Authors:  Yojiro Hashiguchi; Kei Muro; Yutaka Saito; Yoshinori Ito; Yoichi Ajioka; Tetsuya Hamaguchi; Kiyoshi Hasegawa; Kinichi Hotta; Hideyuki Ishida; Megumi Ishiguro; Soichiro Ishihara; Yukihide Kanemitsu; Yusuke Kinugasa; Keiko Murofushi; Takako Eguchi Nakajima; Shiro Oka; Toshiaki Tanaka; Hiroya Taniguchi; Akihito Tsuji; Keisuke Uehara; Hideki Ueno; Takeharu Yamanaka; Kentaro Yamazaki; Masahiro Yoshida; Takayuki Yoshino; Michio Itabashi; Kentaro Sakamaki; Keiji Sano; Yasuhiro Shimada; Shinji Tanaka; Hiroyuki Uetake; Shigeki Yamaguchi; Naohiko Yamaguchi; Hirotoshi Kobayashi; Keiji Matsuda; Kenjiro Kotake; Kenichi Sugihara
Journal:  Int J Clin Oncol       Date:  2019-06-15       Impact factor: 3.402

View more
  2 in total

1.  Tumor Budding as a Predictive Marker of Relapse and Survival in Patients With Stage II Colon Cancer.

Authors:  Kazuyuki Saito; Takashi Okuyama; Shunya Miyazaki; Haruka Oi; Takashi Mitsui; Takuji Noro; Emiko Takeshita; Yuko Ono; Taizen Urahashi; Hidehiro Tajima; Hideyuki Yoshitomi
Journal:  In Vivo       Date:  2022 Jul-Aug       Impact factor: 2.406

2.  Endoscopic intermuscular dissection with intermuscular tunneling for local resection of rectal cancer with deep submucosal invasion.

Authors:  Hao Dang; James C H Hardwick; Jurjen J Boonstra
Journal:  VideoGIE       Date:  2022-04-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.